Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 ETI, University of Oklahoma To Share Technology - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

ETI, University of Oklahoma To Share Technology

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Emergent Technologies Inc. (ETI), Austin, TX, has licensed recombinant chondroitin technology from the University of Oklahoma Health Sciences Center (OUHSC), Oklahoma City, OK. ETI has formed a new company, Choncept L.L.C., to commercialize the technology that was developed by Dr. Paul DeAngelis, an associate professor at OUHSC. The new method of chondroitin production utilizes bacteria, not animal sources, avoiding the problems of potential prion contamination (“mad cow”) or harvesting endangered animals such as sharks. In addition, Choncept will be able to create novel re­combinant molecules, called chimerics, by joining chondroitin, hyaluronic acid and heparin. All of this will be possible through cooperation with sister companies Halose and Heparinex.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters